SonoCloud-9 Enhances Carboplatin Delivery in Recurrent Glioblastoma Trial
The SonoCloud-9 device aims to enhance the delivery of carboplatin to brain tumors by temporarily opening the blood-brain barrier.
Asset / Drug
Drug and asset intelligence for Carboplatin with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.